LONDON, UK – The European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) "has adopted a positive opinion" on extending the marketing authorization for apixaban (Eliquis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback